Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLOZ-AID: Clozapine for Treatment-Resistant Psychosis in Intellectual Disability
NCT04529226Phase 2Active, not recruiting
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Nov 2020
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of clozapine in psychosis, sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Started Nov 2020; status: active, not recruiting.
02
Drugs
clozapine
03
Conditions
psychosis
Beyond the preview
Go deeper on NCT04529226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04529226.